NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Female orgasmic disorder? CBC airs indepth disease-mongering discussion

The Canadian Broadcasting Corporation’s (CBC) program, The Current, reported: “Drug to treat Female Orgasmic Disorder under speculation.”

The brief program description:

“Trials of a new drug to help treat a condition known as female orgasmic disorder are underway in Canada. But critics say there’s no such thing, and this is really about drug manufacturing and marketing.”

The healthy skeptic on the program (about 12 minutes deep in the audio below) was Dr. Barbara Mintzes, Assistant Professor in the Department of Anesthesiology, Pharmacology & Therapeutics at the University of British Columbia. The main focus of her research is on the effects of drug promotion, including direct-to-consumer advertising, on prescribing and medicine use. She also works with UBC’s Therapeutics Initiative to carry out systematic reviews on the beneficial and harmful effects of new drugs. She’s also co-author of the book, “Sex, Lies and Pharmaceuticals: How Drug Companies Plan to Profit from Female Sexual Dysfunction.”

PLAY THE PROGRAM HERE

The program is a classic discussion of concerns about disease-mongering. Kudos to CBC and The Current for educating listeners. It’s a 24-minute program well worth your time.

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.